The DOI matches its Crossref record; 280 of the 286 references it cites were found in a registry or an index.
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“According to the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, there is likely no lower limit on the amount of moderate-to-vigorous physical activity at which benefits for ASCVD risk start to accrue, and effort should be made to promote achievement of the minimum recommended amount of physical activity (44).”
From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation
Research works printed but not linked: 13
- DeFilippis, 2017, Eur Heart J, 38, 598
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
- Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 · DOI · Paper page
- Mortensen, 2016, A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study, J Am Coll Cardiol, 68, 881, 10.1016/j.jacc.2016.05.084 · DOI
- Nasir, 2015, Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 66, 1657, 10.1016/j.jacc.2015.07.066 · DOI
- Yano, 2017, Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies, JAMA Cardiol, 2, 986, 10.1001/jamacardio.2017.2498 · DOI
- Budoff, 2018, Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA), Eur Heart J, 39, 2401, 10.1093/eurheartj/ehy217 · DOI · Paper page
- Whelton, 2018, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 · DOI · Paper page
- Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group, N Engl J Med, 344, 3, 10.1056/NEJM200101043440101 · DOI · Paper page
- Bress, 2017, Cost-effectiveness of intensive versus standard blood-pressure control, N Engl J Med, 377, 745, 10.1056/NEJMsa1616035 · DOI
- Patnode, 2015, Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force, Ann Intern Med, 163, 608, 10.7326/M15-0171 · DOI · Paper page
- Guirguis-Blake, 2016, Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 164, 804, 10.7326/M15-2113 · DOI
Cited by
Sorted by citations
Items 501–600 of 1,000
Medication Use Quality and Safety in Older Adults: 2018 Update
Ailabouni, N. J., Marcum, Z. A., Schmader, K. E., & Gray, S. L. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16243 · Cited by 11
Gallo, S., & Cheskin, L. J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.10.003 · Cited by 12
Cao, Y., Li, L., Zhang, H., Jin, J., Liu, H., Guo, Y., Wu, N., Zhu, C., Dong, Q., Xu, R., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5324 · Cited by 10
“Dyslipidemia has been widely considered as a primary cause of coronary artery disease (CAD) and this notion is supported by major clinical guidelines (1,2).”
BackgroundWu, Y., Juraschek, S. P., Hu, J., Mueller, N. T., Appel, L. J., Anderson, C. A. M., & Miller, E. R. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab128 · Cited by 10
Kim, S. J., Kwon, O. D., Lee, E., Ock, S. M., & Kim, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254907 · Cited by 10
Implementation of a self-determination based clinical program to reduce cardiovascular disease risk
Mayo, N. L., Russell, H. A., Holt, K. D., & Williams, G. C. (2022) · Journal of Health Psychology · doi:10.1177/13591053211068124 · Cited by 10
“The clinical team was intensively trained to deliver AHA-ACC health behavior guidelines (Arnett et al., 2019; Gerhard-Herman et al., 2017; Stone et al., 2014) using an approach that has been shown to facilitate internalization for valuing and enhancing autonomous motivation and perceived competence…”
MethodZhang, L., Niu, M., Zhang, H., Wang, Y., Zhang, H., Mao, Z., Zhang, X., He, M., Wu, T., Wang, Z., et al. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104746 · Cited by 10
Hyperlipidemia management in diabetes: First line or supportive therapy?
Gupta, R., & Misra, A. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102470 · Cited by 10
Hashemi, A., Vasquez, K., Guishard, D., Naji, M., Ronning, A., George-Alexander, G., Vasquez, D., Sylvester, C., Pagano, W., Khalida, C., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.05.018 · Cited by 12
Aspirin for primary prevention in the elderly
Saad, M. S., Abdelaziz, H. K., & Mehta, J. L. (2019) · Aging · doi:10.18632/aging.102255 · Cited by 11
Venkataraman, P., Neil, A. L., Mitchell, G. K., Stanton, T., Nicholls, S. J., Tonkin, A. M., Watts, G. F., & Marwick, T. H. (2023) · The Medical Journal of Australia · doi:10.5694/mja2.51860 · Cited by 9
Stratification of Atherosclerosis based on Plasma Metabolic States
Menaker, Y., van den Munckhof, I., Scarpa, A., Placek, K., Brandes-Leibovitz, R., Glantzspiegel, Y., Joosten, L. A. B., Rutten, J. H. W., Netea, M. G., Gat‐Viks, I., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad672 · Cited by 9
Carrillo-Larco, R. M. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132423 · Cited by 9
Gholamhoseini, M. T., Kermani, S. A., Yazdi‐Feyzabadi, V., & Goudarzi, R. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11808-0 · Cited by 9
Rosenblatt, S., Blaha, M. J., Blankstein, R., Nasir, K., Lin, F. Y.-H., Yeboah-Kordieh, Y., Berman, D. S., Miedema, M. D., Whelton, S. P., Rumberger, J. A., et al. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.01.013 · Cited by 9
Self-citationDiretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025
Rached, F. H., Miname, M. H., Rocha, V. Z., Zimerman, A., Cesena, F. Y., Sposito, A. C., Santos, R. D., Behr, P. E. B., Bianco, H. T., Alves, R. J., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250640 · Cited by 42
Life’s Simple 7 score and cardiovascular health in cancer survivors: the Moli-sani study
Bonaccio, M., Castelnuovo, A. F. D., Costanzo, S., Martínez, C. F., Panzera, T., Curtis, A. D., Magnacca, S., Persichillo, M., Cerletti, C., Donati, M. B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf838 · Cited by 9
Cardiovascular risk independently predicts small functional bladder storage capacity
Monaghan, T. F., Miller, C. D., Agudelo, C. W., Rahman, S. N., Everaert, K., Birder, L. A., Wein, A. J., Weiss, J. P., & Lazar, J. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02616-6 · Cited by 9
Kousios, A., Κouis, P., Hadjivasilis, A., & Panayiotou, A. G. (2020) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358120954939 · Cited by 9
Hong, T., Su, Q., Li, X., Shan, Z., Chen, L., Peng, Y., Chen, L., Yan, L., Bao, Y., Lyu, Z., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3416 · Cited by 9
Evaluating coronary artery calcification with low-dose chest CT reconstructed by different kernels
An, S. H., Fan, R., Zhao, B., Qian, Y., Sun, Y., Shi, X., Zhu, Y., Xiao, Y., & Liu, S. (2022) · Clinical Imaging · doi:10.1016/j.clinimag.2021.12.024 · Cited by 9
Richter, C. K., Skulas‐Ray, A. C., Gaugler, T. L., Meily, S., Petersen, K. H., & Kris‐Etherton, P. M. (2022) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.2014369 · Cited by 9
Greco, A., Brugnera, A., Adorni, R., Tasca, G. A., Compare, A., Viganò, A., Fattirolli, F., Giannattasio, C., D'Addario, M., & Steca, P. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110974 · Cited by 11
Management of Mild-to-Moderate Hypertriglyceridemia
Pulipati, V. P., Brinton, E. A., & Hatipoğlu, B. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.07.003 · Cited by 9
Pitta, N. C., Furuya, R. K., Freitas, N. D. O., Dessotte, C. A. M., Dantas, R. A. S., Ciol, M. A., Schmidt, A., & Rossi, L. A. (2022) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2022.100443 · Cited by 9
Choi, Y., Jacobs, D. R., Kramer, H., Shroff, G. R., Chang, A. R., & Duprez, D. A. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.12.001 · Cited by 9
Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease
Peterson, B. E., Bhatt, D. L., Ballantyne, C. M., de Lemos, J. A., Rosenson, R. S., Kosiborod, M., Cannon, C. P., & GOULD Investigators (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4709 · Cited by 9
Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target
Xu, C. (2023) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107193 · Cited by 9
Cystic fibrosis and the cardiovascular system: the unexpected heartache
Hebestreit, H. U., & Thornton, C. S. (2023) · European Respiratory Journal · doi:10.1183/13993003.01253-2023 · Cited by 9
Kilkenny, K., & Frishman, W. H. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000639 · Cited by 9
Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.
Sinh, P., & Cross, R. K. (2024) · PubMed Central · Cited by 9
for the American Society for Preventive Cardiology, Wong, N. D., Amsterdam, E. A., Ballantyne, C. M., Khera, A., Nasir, K., & Toth, P. P. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00358-0 · Cited by 9
Self-citationZhao, Y., Jeyaraman, K., Burgess, P., Connors, C. M., Guthridge, S. L., Maple-Brown, L. J., & Falhammar, H. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-030034 · Cited by 10
Baker, L. H., Boonstra, P. S., Reinke, D. K., Antalis, E. P., Zebrack, B., & Weinberg, R. L. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.36 · Cited by 9
Halford, J. L., Weng, L.-C. C., Choi, S. H., Jurgens, S. J., Morrill, V. N., Khurshid, S. S., Trinquart, L., Benjamin, E. J., Ellinor, P. T., & Lubitz, S. A. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003111 · Cited by 9
Predicting cardiovascular disease risk across the atherosclerotic disease continuum
Poppe, K., Wells, S., Jackson, R., Doughty, R. N., & Kerr, A. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa098 · Cited by 9
Kitkungvan, D., Johnson, N. P., Kirkeeide, R. L., Haynie, M., Carter, C., Patel, M., Bui, L., Madjid, M., Mendoza, P., Roby, A. E., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.03.012 · Cited by 10
¿Qué es la Medicina del Estilo de Vida y por qué la necesitamos?
Izcue, J., Cordero, M. J., Plaza, M., Correa, P., & Hidalgo, A. (2021) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2021.01.010 · Cited by 15
Wang, H., Wu, X., Gu, Y., Zhou, J., & Wu, J. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s330142 · Cited by 9
Min, H. K., Kim, H., Lee, S., Kang, K. Y., Park, S., & Kwok, S. (2022) · Joint Bone Spine · doi:10.1016/j.jbspin.2022.105401 · Cited by 11
Hasson, T. S., Said, E., & Helal, M. G. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120790 · Cited by 9
Sanchez, E. J., & Cefalu, W. T. (2019) · Circulation · doi:10.1161/circulationaha.119.039161 · Cited by 9
Kim, M. C., Ahn, Y., Kim, M. H., Kim, S., Hong, T. J., Rhee, M., Kim, S., Hong, S. J., Kim, H., Kim, W., et al. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00590-9 · Cited by 8
Hu, M., Li, B., Yang, T., Yang, Y., & Yin, C. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.01.005 · Cited by 11
Marchandot, B., Faller, É., Akladios, C. Y., Matsushita, K., Bäck, M., Jesel, L., Schini‐Kerth, V. B., & Morel, O. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae087 · Cited by 8
Tan, C., Chen, J., Tu, T., Chen, L., & Zou, J. (2024) · Open Medicine · doi:10.1515/med-2024-0973 · Cited by 8
Statistically Significant Association Does not Imply Improvement in Prediction of Clinical Outcomes
Jiang, S., ROSNER, B. A., & Colditz, G. A. (2025) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-25-0056 · Cited by 9
Dietary intake is associated with neuropsychological impairment in women with HIV
Rubin, L. H., Gustafson, D., Warrior, L., Sheira, L. A., Fitzgerald, K. C., Dastgheyb, R. M., Weber, K. M., Tien, P. C., French, A. L., Spence, A. B., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab038 · Cited by 8
Çelik, O., Çil, C., Başaran, Ö., Demirci, E., Tanık, V. O., Altuntaş, E., Sancar, K. M., Örsçelik, Ö., Yetim, M., Bekar, L., et al. (2021) · Balkan Medical Journal · doi:10.5152/balkanmedj.2021.21143 · Cited by 8
Dietrich, E., Jomard, A., & Osto, E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.989428 · Cited by 9
Karamanos, E., Hazboun, R., Saad, N. H., Bialowas, C., Wang, H., & Cromack, D. T. (2022) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000004719 · Cited by 8
Greco, A., Adorni, R., Matteis, C. D., D’Αddario, M., Fattirolli, F., Franzelli, C., Giannattasio, C., Luyckx, K., & Steca, P. (2023) · Health Psychology Open · doi:10.1177/20551029231167836 · Cited by 8
“Tackling CVDs is a health issue and a growing economic and societal challenge (Arnett et al., 2019; Timmis et al., 2020).”
BackgroundCardiometabolic predictors of high-risk CCTA phenotype in a diverse patient population
Kuno, T., Arce, J., Fattouh, M., Sarkar, S., Skendelas, J., Daich, J., Schenone, A., Zhang, L.-L., Rodriguez, C. J., Virani, S., et al. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100578 · Cited by 7
Self-citationWang, Y., Sargisson, O., Nguyen, D. T., Parker, K., Pyke, S. J. R., Alramahi, A., Thihlum, L., Fang, Y., Wallace, M. E., Berzins, S. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115955 · Cited by 8
Grinspoon, S. K., Watanabe, M., Ribaudo, H. J., Bloomfield, G. S., Fichtenbaum, C. J., Umbleja, T., Chu, S. M., Fitch, K. V., Diggs, M. R., Zhao, S. J., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf210 · Cited by 9
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults
Safarova, M. S., Weintraub, S. F., Sadaniantz, K. A., Kovell, L. C., Warden, B. A., Garshick, M. S., Duell, P. B., & Gianos, E. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01298-8 · Cited by 8
“These include the QRISK2 and QRISK3 scores, EULAR recommendations to multiply risk models by 1.5 [11], and ACC/AHA recommendations to incorporate RA as a ASCVD-risk enhancer [12].”
InfluentialGarnett, C. E., Johannesen, L., & McDowell, T. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1690 · Cited by 8
Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms
Contois, J. H., Nguyen, R.-A., & Albert, A. L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.02.030 · Cited by 8
KASE, N. G., Friedman, E. G., & Brodman, M. L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.008 · Cited by 8
Conte, E., Mushtaq, S., Marchetti, D., Mallia, V., Belmonte, M., Melotti, E., Pontone, G., Pepi, M., & Andreini, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030521 · Cited by 8
Li, J., Zhang, Z., Si, S., & Xue, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.644573 · Cited by 8
Choi, H.-G., Kim, H.-J., & Kang, S. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001887 · Cited by 8
Batista, E. S., Rios, T. D. S., Muñoz, V. R., de Jesus, J. S., Vasconcelos, M. M., da Cunha, D. T., Marques-Rocha, J. L., Nakandakari, S. C. B. R., Lara, R., da Silva, A. S. R., et al. (2021) · Trials · doi:10.1186/s13063-021-05702-x · Cited by 8
Zinterl, I., Ittermann, T., Schipf, S., Groß, S., Anspieler, H., Kim, S., Ewert, R., Bülow, R., Kühn, J., Lerch, M. M., et al. (2022) · Liver International · doi:10.1111/liv.15162 · Cited by 8
Wright, A. J., Stavres, J., Galloway, R., Donahue, P. T., Sha, Z., & McCoy, S. M. (2022) · European Journal of Applied Physiology · doi:10.1007/s00421-022-05079-y · Cited by 9
dos Santos, S. D. F., Costa, P. N. D. R., Gouvêa, T. G., de Almeida, N. F. A., & Cardoso, F. D. S. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.01.005 · Cited by 8
Massmann, A., Heukelom, J. V., Green, R. C., Hajek, C. A., Hickingbotham, M. R., Larson, E. A., Lu, C. Y., Wu, A. C., Zoltick, E. S., Christensen, K. D., et al. (2023) · Pharmacogenomics · doi:10.2217/pgs-2023-0056 · Cited by 8
Caterina, R. D., Aimo, A., & Ridker, P. M. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-3400294 · Cited by 8
Lebensstilintervention in der Primärprävention von kardiovaskulären Erkrankungen
Heinicke, V., & Halle, M. (2020) · Herz · doi:10.1007/s00059-019-04886-y · Cited by 11
Shoenbill, K., Song, Y.-Q., Craven, M., Johnson, H., Smith, M. A., & Mendonça, E. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106061 · Cited by 9
A module of multifactor‐mediated dysfunction guides the molecular typing of coronary heart disease
Li, Y., Lin, M., Wang, K., Zhan, Y., Gu, W., Gao, G.-H., Huang, Y., Chen, Y., Huang, T., & Wang, J. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1415 · Cited by 8
“This may lead to myocardial ischemia and hypoxia in patients (Arnett et al., 2019; Thygesen et al., 2018).”
BackgroundPreventive Cardiology and Risk Assessment: Beyond LDL
Goyal, A., & Cho, L. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00876-2 · Cited by 8
Ning, H., Kershaw, K. N., Allen, N. B., Wilkins, J. T., & Lloyd‐Jones, D. M. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100222 · Cited by 8
Self-citationAkkaya, H., Güntürk, E. E., Akkaya, F., Karabıyık, U., Güntürk, İ., & Yılmaz, S. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210573 · Cited by 8
The Pooled Cohort Equations and the Test of Time
Lloyd‐Jones, D. M. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.024 · Cited by 8
Self-citationTsai, M., Chen, M., Huang, Y.-C., Liou, H., & Fang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.804000 · Cited by 7
Prediction of low-density lipoprotein cholesterol levels using machine learning methods
Kim, Y., Lee, W. K., & Lee, W. (2024) · Laboratory Medicine · doi:10.1093/labmed/lmad114 · Cited by 7
Yoo, J. Y., Kang, S. R., & Chun, E. J. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070757 · Cited by 7
“Therefore, the CAC score is recommended for the assessment of asymptomatic middle-aged populations, particularly intermediate-risk cohorts, by various cardiovascular society guidelines across the world [5,6].”
BackgroundTuersun, G., Alifu, J., Qu, Y., & Kang, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-77019-z · Cited by 7
Artificial Intelligence in Cardiovascular Diseases
Bashir, S., Ahanger, A. N., Assad, A., Bhat, M. R., & Macha, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-8176-1_10 · Cited by 8
Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease
Razavi, A. C., Chen, J., Yang, W. P., Sha, D., Dzaye, O., Bhatia, H. S., Tsimikas, S., Lash, J. P., Kansal, M. M., Rincon-Choles, H., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102068 · Cited by 9
Self-citationGarshick, M. S., Drenkova, K., Kazatsker, F., Boothman, I., Muller, M. A., Schlamp, F., Luttrell-Williams, E. S., Sicco, K. L., Neimann, A. L., Scher, J. U., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322574 · Cited by 7
Obesity and Acute Pulmonary Embolism
Zuin, M., Piazza, G., Barco, S., Bertoletti, L., Ciurzyński, M., Skoro‐Sajer, N., Kurzyna, M., Mouratoglou, S., Hobohm, L., & Klok, F. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.1504 · Cited by 8
Colmenero, J., Crespo, G., Wandji, L. C. N., Fundora, Y., & Louvet, A. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101704 · Cited by 7
Kaptoge, S. K., Keene, S. J., Reitsma, T. H., Shi, W., Lees, J. S., Loo, L., Gynnild, M. N., Chilala, C. I., Ritchie, S. C., Spackman, S., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag154 · Cited by 9
Self-citationLazar, J., Chobufo, M. D., Weiss, J. P., Everaert, K., Backer, T. L. M. D., Wein, A. J., Brunicardi, F. C., & Monaghan, T. F. (2021) · Journal of Community Health · doi:10.1007/s10900-021-00962-9 · Cited by 7
Lim, C. Y., Ho, J. S., Huang, Z., Gao, F., Tan, S. Y., Koh, W., Chua, T. S. J., Low, L. P., Tan, H. C., & Yoon, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256218 · Cited by 7
Liu, M., Jia, J., Fan, F., Sun, P., Wu, Z., Jiang, Y., He, D., Liu, B., Yang, Y., & Zhang, Y. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050254 · Cited by 7
Espel‐Huynh, H., Goldstein, C. M., Stephens, M. L., Finnegan, O. L., Elwy, A. R., Wing, R. R., & Thomas, J. G. (2021) · Translational Behavioral Medicine · doi:10.1093/tbm/ibab160 · Cited by 6
Sjúrðarson, T., Kyhl, K., Nordsborg, N. B., Kollslíð, R., Andersen, L. J., Krustrup, P., & Mohr, M. (2024) · European Journal of Applied Physiology · doi:10.1007/s00421-023-05399-7 · Cited by 7
“In 1999, women-specific guidelines for CVD prevention were developed by the American Heart Association (AHA) (Mosca et al. 1999), which emphasized the importance of regular physical exercise as an adjunct to the pharmacological treatment and prevention of CVD. Specifically, the most recent women-specific guidelines fr…”
BackgroundJia, Y., & Leung, S.-W. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117925 · Cited by 7
Vascular health years after a hypertensive disorder of pregnancy: The EPOCH study
Miller, H. E., Tierney, E. S. S., Stefanick, M. L., Mayo, J. A., Sedan, O., Rosas, L. G., Melbye, M., Boyd, H. A., Stevenson, D. K., Shaw, G. M., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.03.004 · Cited by 7
Uthman, O. A., Al-Khudairy, L., Nduka, C. U., Court, R. A., Enderby, J., Anjorin, S., Mistry, H., Meléndez‐Torres, G. J., Taylor‐Phillips, S., & Clarke, A. (2023) · Health Technology Assessment · doi:10.3310/gjtr5006 · Cited by 8
Siddiqui, R. W., Nishat, S. M. H., Alzaabi, A. A., Alzaabi, F. M., Tarawneh, D. J. A., Tarawneh, Y. J. A., Khan, A., Khan, M. A. M., Siddiqui, T. W., & Siddiqui, S. W. (2024) · Cureus · doi:10.7759/cureus.72302 · Cited by 7
Current status and future perspective of coronary artery calcium score in asymptomatic individuals
Kawaguchi, Y. O., Fujimoto, S., Nozaki, Y. O., Tomizawa, N., Daida, H., & Minamino, T. (2024) · Journal of Cardiology · doi:10.1016/j.jjcc.2024.11.008 · Cited by 7
Assessment of the benefit–risk balance of SGLT2 inhibitors: Commentary on a new ‘French paradox’
Scheen, A. J., Darmon, P., & Hanaire, H. P. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.04.001 · Cited by 7
Lee, S., Villines, T. C., & Chang, H. (2019) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2019.06.017 · Cited by 7
Coronary artery calcification: More than meets the eye
Huang, X., D’Addabbo, J., & Nguyen, P. K. P. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02058-8 · Cited by 7
Halboup, A. M., Othman, G. Q., Battah, M., Alzoubi, K. H., & Sallom, H. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s265118 · Cited by 7
Abdo, M., Langan, S. J., MaWhinney, S., Sun, J., Lake, J. E., Palella, F. J., Kingsley, L., Brown, T. T., & Erlandson, K. M. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002579 · Cited by 7
Metadata
- Authors
- Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B.
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 74
- Issue
- 10
- Pages
- 1376-1414
- ISSN
- 0735-1097 (ISSN-L)
- PMC
- PMC8344373
- OpenAlex
- W2984766121
- Cited by
- 1,193
- References
- 286
- Citations by year
- 2026: 87 · 2025: 140 · 2024: 131 · 2023: 167 · 2022: 191 · 2021: 207 · 2020: 191 · 2019: 79
- FWCI
- 153.80
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Heart Association (17SDG33630113)
- National Institutes of Health (KL2TR001882)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- primary prevention, cardiovascular disease, cardiovascular risk factors, cardiovascular disease prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review